Cargando…
Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer
The poor prognosis of pancreatic cancer is primarily due to the development of resistance to therapies, including gemcitabine. The long noncoding RNA PVT1 (lncRNA PVT1) has been shown to interact with enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2), promoting gemcitabine resistance...
Autores principales: | Sun, Yan, Ren, Dianyun, Zhou, Yingke, Shen, Jian, Wu, Heshui, Jin, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464605/ https://www.ncbi.nlm.nih.gov/pubmed/34564701 http://dx.doi.org/10.1038/s41419-021-04118-4 |
Ejemplares similares
-
NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15
por: Guo, Feng, et al.
Publicado: (2021) -
Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer
por: Fan, Ping, et al.
Publicado: (2019) -
The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020) -
Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression
por: Dangi-Garimella, Surabhi, et al.
Publicado: (2013) -
HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer
por: Zhou, Yingke, et al.
Publicado: (2022)